HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deepak Shukla Selected Research

Viral Proteins

10/2021Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deepak Shukla Research Topics

Disease

75Infections
03/2024 - 10/2002
23Herpes Simplex
03/2024 - 10/2002
18Virus Diseases (Viral Diseases)
11/2023 - 04/2011
9Inflammation (Inflammations)
06/2023 - 10/2004
5Disease Progression
03/2024 - 01/2021
5Keratitis
03/2024 - 02/2015
5COVID-19
09/2022 - 06/2020
5Eye Infections
04/2022 - 09/2013
5Neoplasms (Cancer)
12/2021 - 08/2006
3Herpes Genitalis (Genital Herpes)
10/2023 - 01/2016
3Herpesviridae Infections (Herpesvirus Infection)
09/2023 - 12/2008
3Wounds and Injuries (Trauma)
01/2021 - 01/2017
2Cytokine Release Syndrome
01/2022 - 01/2022
2Latent Infection
01/2019 - 04/2013
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2023
1Reinfection
01/2023
1Coronavirus Infections
06/2022
1Osteonecrosis (Kienbock's Disease)
03/2022
1Periapical Periodontitis (Apical Periodontitis)
01/2022
1Periodontitis
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021
1Neoplasm Metastasis (Metastasis)
03/2021
1Corneal Opacity
01/2021
1Herpetic Keratitis
10/2019
1Pathologic Processes
02/2019
1Melanoma (Melanoma, Malignant)
10/2018

Drug/Important Bio-Agent (IBA)

20Antiviral Agents (Antivirals)IBA
10/2023 - 08/2010
18Proteins (Proteins, Gene)FDA Link
12/2022 - 10/2004
12Heparitin Sulfate (Heparan Sulfate)IBA
01/2020 - 09/2005
10heparanaseIBA
03/2024 - 04/2015
10BX795IBA
10/2023 - 01/2018
10Peptides (Polypeptides)IBA
01/2023 - 07/2011
8CytokinesIBA
01/2022 - 04/2013
8NectinsIBA
04/2013 - 10/2004
7VaccinesIBA
09/2022 - 04/2013
6HCEIBA
12/2022 - 11/2010
6Acyclovir (Aciclovir)FDA LinkGeneric
04/2022 - 09/2013
6Glycoproteins (Glycoprotein)IBA
02/2019 - 10/2002
5NucleosidesIBA
10/2023 - 06/2016
5EnzymesIBA
01/2021 - 11/2014
4Zinc OxideFDA Link
01/2019 - 12/2012
3MicroRNAs (MicroRNA)IBA
02/2024 - 01/2018
3CarbonIBA
10/2022 - 01/2019
3DNA (Deoxyribonucleic Acid)IBA
03/2021 - 04/2015
3Protein Isoforms (Isoforms)IBA
11/2014 - 10/2002
3Cytochalasin DIBA
01/2013 - 08/2008
2Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
03/2024 - 01/2011
2NF-kappa B (NF-kB)IBA
06/2023 - 04/2015
2Glycoside Hydrolases (Endoglycosidases)IBA
01/2023 - 09/2017
2Liposomes (Liposome)IBA
12/2022 - 01/2016
2COVID-19 VaccinesIBA
09/2022 - 06/2022
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 01/2019
2Syndecan-1 (Syndecan 1)IBA
01/2020 - 04/2011
1SuspensionsIBA
11/2023
1Fluorescein (Funduscein)FDA LinkGeneric
11/2023
1Ionic LiquidsIBA
10/2023
1Scopolamine (Hyoscine)FDA Link
01/2023
1Fatty Acids (Saturated Fatty Acids)IBA
12/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2022
1Protein Kinase CIBA
12/2022
1NucleotidesIBA
10/2022
1BBV152 COVID-19 vaccineIBA
09/2022
1ChAdOx1 nCoV-19IBA
09/2022
1mRNA VaccinesIBA
06/2022
1Subunit VaccinesIBA
06/2022
1Inactivated VaccinesIBA
06/2022
12-benzyl-3-formylpropanoic acid (BFP)IBA
03/2022
1compstatinIBA
01/2022
1Complement Inactivating AgentsIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1NexusIBA
01/2022
1CateninsIBA
12/2021
1Antimicrobial PeptidesIBA
12/2021
1HistatinsIBA
12/2021
1CholesterolIBA
12/2021
1sigma-2 receptorIBA
12/2021
1TOR Serine-Threonine KinasesIBA
10/2021
1Mechanistic Target of Rapamycin Complex 2IBA
10/2021
1OligonucleotidesIBA
10/2021
1Viral ProteinsIBA
10/2021
1Virus ReceptorsIBA
01/2021
14-phenylbutyric acid (Buphenyl)FDA Link
12/2020
1Carboxylic AcidsIBA
11/2020
1PolymersIBA
11/2020
1Virulence Factors (Pathogenicity Factors)IBA
01/2020
1Matrix Metalloproteinases (MMPs)IBA
01/2020
1Metalloproteases (Metalloproteinases)IBA
01/2020
1ProdigiosinIBA
01/2020
1Cell Surface ReceptorsIBA
02/2019
1Cathepsin LIBA
12/2018
1Enzyme Precursors (Zymogens)IBA
12/2018
1matrigelIBA
10/2018
1dimemorfan (AT 17)IBA
10/2018
1Phosphotransferases (Kinase)IBA
01/2018
1A-Form DNA (A-DNA)IBA
12/2017

Therapy/Procedure

20Therapeutics
10/2023 - 01/2012
2Immunomodulation
12/2021 - 01/2021
2Contact Lenses
01/2021 - 01/2016
1Duration of Therapy
01/2019
1Oncolytic Virotherapy
10/2018